Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal contacts as early as 11 years before the expected onset of dementia symptoms.

A pause to NIH funding has researchers scrambling for contingency plans at the University of Washington’s Alzheimer’s Disease Research Center. The center’s brain bank is preserving more than 4,000 ...

“We don’t have the ability to predict who’s going to get worse because we won’t be able to see them,” said DeCarli, who’s ...

A research team at the Institute for Basic Science (IBS) has identified a previously unknown enzyme, SIRT2, that plays a key ...

Scientists Identify Key Enzyme in Alzheimer's Disease That Links Brain Inflammation to Memory Loss Apr. 14, 2025 — A research team has identified a previously unknown enzyme, SIRT2, that plays a ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

Having already been hailed for their ability to aid weight loss and treat diabetes, GLP-1 drugs like Ozempic and Mounjaro ...

Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

He says this is a crucial time for brain disease research, as drugs are being developed that show potential to treat the underlying causes of Alzheimer's rather than just slowing its symptoms.

For years, people have believed that being married protects your health and helps you live longer. Studies have shown that ...

Two significant programs that invested in research on diabetes, dementia, obesity and kidney disease have ended since the ...

“We’re about to enter the era of personalized medicine for Alzheimer’s disease,” co-lead researcher Kanta Horie, a research ...